Most cited papers from Santen (United States)

Santen (United States)

What are the most cited papers from Santen (United States)?

The most cited paper from Santen (United States) is "Industrial perspective in ocular drug delivery" (Yusuf Ali, Kari Lehmussaari, 2006), with 171 citations. Next come "Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial" (170) and "Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma" (147).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 19 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Industrial perspective in ocular drug delivery Yusuf Ali, Kari Lehmussaari · Advanced Drug Delivery Reviews	18 Sep 2006	171
2	Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial Stephen E. Straus, Anna Wald, Rhonda G. Kost et al. · The Journal of Infectious Diseases Open access	Nov 1997	170
3	Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma Henny J. M. Beckers, Florent Aptel, Carroll A.B. Webers et al. · Ophthalmology Glaucoma Open access	28 Jul 2021	147
4	Optic Nerve Head and Retinal Nerve Fiber Layer Analysis Shan C. Lin, Kuldev Singh, HENRY D. JAMPEL et al. · Ophthalmology Open access	Oct 2007	135
5	Optical sensors for monitoring dynamic changes of intracellular metabolite levels in mammalian cells Bi‐Huei Hou, Hitomi Takanaga, Guido Großmann et al. · Nature Protocols	27 Oct 2011	122
6	Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension Makoto Aihara, Fenghe Lu, Hisashi Kawata et al. · American Journal of Ophthalmology Open access	10 Jun 2020	101
7	Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study Quan Dong Nguyen, Mohamed Abdellah Ibrahim, Anthony Watters et al. · Journal of Ophthalmic Inflammation and Infection Open access	2013	97
8	Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review Omar R. Sadruddin, Leonard Pinchuk, Raymund Angeles et al. · Eye and Vision Open access	15 Nov 2019	96
9	Best Practices for Chiropractic Management of Patients with Chronic Musculoskeletal Pain: A Clinical Practice Guideline Cheryl Hawk, Wayne M. Whalen, Ronald J. Farabaugh et al. · The Journal of Alternative and Complementary Medicine Open access	4 Aug 2020	95
10	Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent Tomoko Kirihara, Takazumi Taniguchi, Kenzo Yamamura et al. · Investigative Ophthalmology & Visual Science Open access	13 Jan 2018	93
11	Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys Masahiro Fuwa, Carol B. Toris, Shan Fan et al. · Journal of Ocular Pharmacology and Therapeutics Open access	10 Jul 2018	92
12	Patients’ Willingness to Allow Residents to Learn to Practice Medical Procedures Sally A. Santen, Robin R. Hemphill, Morgan F. McDonald et al. · Academic Medicine	Feb 2004	83
13	Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma Joseph F. Panarelli et al. · Ophthalmology Open access129 authors	26 Sep 2023	81
14	Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA) Quan Dong Nguyen, Pauline Townsend Merrill, W. Lloyd Clark et al. · Ophthalmology Open access	Oct 2016	81
15	Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies Najam A. Sharif · Frontiers in Pharmacology Open access	17 Sep 2021	72
16	Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma Jean Kim, Max Kudisch, Sri Mudumba et al. · Investigative Ophthalmology & Visual Science Open access	24 Aug 2016	69
17	Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma Peter G. Klimko, Najam A. Sharif · British Journal of Pharmacology Open access	17 Apr 2018	62
18	Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging Yuka Kihara, Giovanni Montesano, Andrew Chen et al. · Ophthalmology Open access	21 Feb 2022	60
19	Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision Najam A. Sharif · Neural Regeneration Research Open access	2018	60
20	Best-Practice Recommendations for Chiropractic Management of Patients With Neck Pain Wayne M. Whalen, Ronald J. Farabaugh, Cheryl Hawk et al. · Journal of Manipulative and Physiological Therapeutics Open access	Nov 2019	59
21	Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms Colleen M McDowell et al. · Investigative Ophthalmology & Visual Science Open access	7 Feb 2022	58
22	Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study Makoto Aihara, Auli Ropo, Fenghe Lu et al. · Japanese Journal of Ophthalmology	22 Jun 2020	55
23	In Vitro Susceptibilities of Bacterial Ocular Isolates to Fluoroquinolones Adrienne L. Graves, Marrieta Henry, Terrence P. O’Brien et al. · Cornea	Apr 2001	55
24	Reporting Achievement of Medical Student Milestones to Residency Program Directors: An Educational Handover Cemal B. Sozener, Monica L. Lypson, Joseph B. House et al. · Academic Medicine	22 Oct 2015	54
25	Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension Makoto Aihara, Fenghe Lu, Hisashi Kawata et al. · Journal of Glaucoma Open access	5 Mar 2019	53
26	Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl Ryo Iwamura, Masayuki Tanaka, Eiji Okanari et al. · Journal of Medicinal Chemistry Open access	11 Jul 2018	52
27	Racial and Ethnic Differences in Myopia Progression in a Large, Diverse Cohort of Pediatric Patients Tiffany Q. Luong, Yu‐Hsiang Shu, Bobeck S. Modjtahedi et al. · Investigative Ophthalmology & Visual Science Open access	13 Nov 2020	51
28	Strategies From 11 U.S. Medical Schools for Integrating Basic Science Into Core Clerkships Michelle M. Daniel, Gail Morrison, Karen E. Hauer et al. · Academic Medicine	29 Dec 2020	48
29	Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility Najam A. Sharif, Peter G. Klimko · British Journal of Pharmacology Open access	21 Apr 2018	47
30	Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study Makoto Aihara, Fenghe Lu, Hisashi Kawata et al. · Japanese Journal of Ophthalmology	8 Sep 2021	46
31	Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences. Dai Miyazaki, Grace Liu, Leslie Horn Clark et al. · PubMed	Nov 2000	46
32	Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells Padma Bezwada, Leslie A. Clark, Susan M. Schneider · Current Medical Research and Opinion	21 Dec 2007	44
33	Tolerability and Pharmacokinetics of Intravitreal Sirolimus Sri Mudumba, Padma Bezwada, Hitomi Takanaga et al. · Journal of Ocular Pharmacology and Therapeutics	4 Jun 2012	42
34	Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent Jean Kim, Max Kudisch, Nina Rosa Konichi da Silva et al. · Journal of Controlled Release Open access	7 Nov 2017	41
35	i Drugs and i Devices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants Najam A. Sharif · Journal of Ocular Pharmacology and Therapeutics	11 Jan 2018	40
36	Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers Michael B. Raizman, Jay M. Rubin, Adrienne L. Graves et al. · Clinical Therapeutics	Sep 2002	40
37	Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future Leonard A. Levin, Christopher M. Patrick, Nozhat B. Choudry et al. · Frontiers in Neurology Open access	12 Aug 2022	38
38	Diabetic retinopathy: a review June Chu, Yusuf Ahmed Ali · Drug Development Research	Feb 2008	38
39	Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients Steven J. Lichtenstein, Mike Rinehart · Journal of American Association for Pediatric Ophthalmology and Strabismus	Oct 2003	36
40	The Accelerating Change in Medical Education Consortium: Key Drivers of Transformative Change Kimberly D. Lomis, Sally A. Santen, Michael Dekhtyar et al. · Academic Medicine	15 Dec 2020	35
41	Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis Quan Dong Nguyen, Pauline Townsend Merrill, Yasir Jamal Sepah et al. · Ophthalmology Open access	27 Jul 2018	35
42	Pemirolast Potassium 0.1% Ophthalmic Solution is an Effective Treatment for Allergic Conjunctivitis: A Pooled Analysis of Two Prospective, Randomized, Double-masked, Placebo-controlled, Phase III Studies Mark B. Abelson, Gregg J. Berdy, Thomas K. Mundorf et al. · Journal of Ocular Pharmacology and Therapeutics	Oct 2002	35
43	The use of polyisobutylene-based polymers in ophthalmology Leonard Pinchuk · Bioactive Materials Open access	21 Sep 2021	34
44	Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment Pauline Townsend Merrill, W. Lloyd Clark, ALAY S. BANKER et al. · Ophthalmology Open access	3 Apr 2020	34
45	In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device Kevin D. Lance, Samuel D. Good, Thaís Sousa Mendes et al. · Investigative Ophthalmology & Visual Science Open access	11 Nov 2015	34
46	FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma Najam A. Sharif, Noriko Odani‐Kawabata, Fenghe Lu et al. · Experimental Eye Research	19 Feb 2023	32
47	Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells Yasuko Yamamoto, Takazumi Taniguchi, Tomoaki Inazumi et al. · Journal of Ocular Pharmacology and Therapeutics Open access	14 Jan 2020	31
48	Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection Catherine Atieno Opere, Segewkal Heruye, Ya-Fatou Njie-Mbye et al. · Journal of Ocular Pharmacology and Therapeutics	21 Dec 2017	29
49	Extended depth-of-focus intraocular lenses: power calculation and outcomes Marco Coassin, Antonio Di Zazzo, Marco Antonini et al. · Journal of Cataract & Refractive Surgery	27 Jun 2020	28
50	Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study) Makoto Aihara, Fenghe Lu, Hisashi Kawata et al. · Journal of Ocular Pharmacology and Therapeutics Open access	Nov 2019	28

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.